Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: A prospective, multi-institutional AIDS Clinical Trials Group Study (ACTG 149)

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 5, 2000, Pages 444-450

  Levine, Alexandra M ^a,f   Li, Ping ^b   Cheung, Tony ^c,g   Tulpule, Anil ^a   Von Roenn, Jamie ^d   Nathwani, Bharat N ^a   Ratner, Lee ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

ABVD; HIV; Hodgkin's disease

Indexed keywords

BLEOMYCIN; CD4 ANTIGEN; DACARBAZINE; DOXORUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MULTICENTER STUDY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; THROMBOCYTOPENIA;

EID: 0034662732     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200008150-00009     Document Type: Article

References (46)

1. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy; Prospective cohort study
2. Declining incidence of Kaposi's sarcoma in AIDS Clinical Trial Group (ACTG) trials
3. Impact of highly effective anti-retroviral therapy on the incidence of malignancies among HIV infected individuals
4. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men
5. Increased incidence of Hodgkin's disease in homosexual men with HIV infection
6. HIV associated Hodgkin's disease: Biologic and clinical aspects
7. Hodgkin's disease in the setting of human immunodeficiency virus infection
8. Hodgkin's disease and AIDS: 23 New cases and a review of the literature
9. HIV associated Hodgkin's Disease: A clinical study of 18 cases and review of the literature
10. Malignant lymphomas in patients with or at risk for AIDS in Italy
11. Human immunodeficiency virus-associated Hodgkin's disease: Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells
12. Hodgkin's Disease associated with HIV: A clinical study of 46 cases
13. Hodgkin's disease in patients with antibodies to human immunodeficiency virus. A study of 22 patients
14. Hodgkin's disease in 92 patients with HIV infection: The Italian experience
15. Hodgkin's disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors
16. AIDS and Hodgkin's Disease
17. Intracerebral Hodgkin's disease in a human immunodeficiency virus seropositive patient
18. Rectal Hodgkin's disease and the acquired immunodeficiency syndrome
19. Hodgkin's disease
20. Problems in Hodgkin's disease management
21. Hodgkin's disease during HIV-1 infection: The French registry experience
22. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection
23. Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus
24. Suppression of in vitro hematopoiesis following human immunodeficiency virus infection
25. Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV infected patients
26. The pathology and nomenclature of Hodgkin's disease
27. Alternating non-cross resistant combination chemotherapy or MOPP in Stage IV Hodgkin's disease
28. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
29. Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival
30. Hodgkin's disease and infection with the human immunodeficiency virus in Italy
31. Hodgkin's disease and the acquired immunodeficiency syndrome
32. Hodgkin's disease in HIV infected intravenous drug abusers
33. Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine, and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF
34. Treatment of human immunodeficiency virus-associated Hodgkin's disease
35. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 Counts of 200 per cubic millimeter or less
36. Feasibility of the integration of Stanford V chemotherapy regimen with highly active antiretroviral therapy and G-CSF in patients with Hodgkin's disease and HIV infection
37. The impact of Hodgkin's disease on the immune system
38. Impaired delayed hypersensitivity response in 154 patients with untreated Hodgkin's disease
39. Impaired lymphocyte function in untreated HD
40. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease
41. Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease
42. Chemotherapy for HIV associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy (HAART) is not associated with excessive toxicity
43. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma
44. Low dose methotrexate, bleomycin, adriamycin, cyclophosphamide, oncovin, and dexamethasone with zalcitabine in patients with AIDS related lymphoma: Effect on HIV and serum IL-6 levels over time
45. Risk of cancer in people with AIDS